Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence, Clinical Characteristics and Evaluation of Prognostic and Diagnostic Markers of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study

NCT03870828 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT03870828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence, Clinical Characteristics and Evaluation of Prognostic and Diagnostic Markers of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study
Lead sponsor
Medical University of Silesia
Phase
Observational
Overall status
Unknown status
Start date
March 18, 2019
Completion date
December 31, 2025
Enrollment
210 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, interstitial fibrosis, interstitial lung disease, interstitial pneumonia